In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions

Semmes, E. C., Nettere, D. R., Nelson, A. N., Hurst, J. H., Cain, D. W., Burt, T. D., Kurtzberg, J., Reeves, R. K., Coyne, C. B., Fouda, G. G., Pollara, J., Permar, S. R., & Walsh, K. M. (2024). In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions. The Journal of clinical investigation135(1), e181342. https://doi.org/10.1172/JCI181342

Natural Killer Cell Phenotypes and Clinical Outcomes in Pediatric Kidney Transplantation

Kahan, R. H., Abraham, N., Lee, H. J., Ettenger, R. B., Grimm, P. C., Reed, E. F., Reeves, R. K., Sarwal, M. M., Stempora, L. L., Warshaw, B. L., Kirk, A. D., Martinez, O. M., & Chambers, E. T. (2024). Natural Killer Cell Phenotypes and Clinical Outcomes in Pediatric Kidney Transplantation. Pediatric transplantation28(8), e14877. https://doi.org/10.1111/petr.14877

Knockdowns of CD3zeta Chain in Primary NK Cells Illustrate Modulation of Antibody-Dependent Cellular Cytotoxicity Against Human Immunodeficiency Virus-1

Sugawara, S., Lee, E., Craemer, M. A., Pruitt, A., Balachandran, H., Gressens, S. B., Kroll, K., Manickam, C., Li, Y., Jost, S., Woolley, G., & Reeves, R. K. (2024). Knockdowns of CD3zeta Chain in Primary NK Cells Illustrate Modulation of Antibody-Dependent Cellular Cytotoxicity Against Human Immunodeficiency Virus-1. AIDS research and human retroviruses40(11), 631–636. https://doi.org/10.1089/AID.2023.0114

Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology

Banga, J., Brock-Fisher, T., Petros, B. A., Dai, E. Y., Leonelli, A. T., Dobbins, S. T., Messer, K. S., Nathanson, A. B., Capone, A., Littlehale, N., Appiah-Danquah, V., Dim, S., Moreno, G. K., Crowther, M., DeRuff, K. C., MacInnis, B. L., Springer, M., Sabeti, P. C., & Stephenson, K. E. (2024). Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology. Open forum infectious diseases11(11), ofae591. https://doi.org/10.1093/ofid/ofae591

SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity

Lasrado, N., Rowe, M., McMahan, K., Hachmann, N. P., Miller, J., Jacob-Dolan, C., Liu, J., Verrette, B., Gotthardt, K. A., Ty, D. M., Pereira, J., Mazurek, C. R., Hoyt, A., Collier, A. Y., & Barouch, D. H. (2024). SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity. Science translational medicine16(770), eadp8920. https://doi.org/10.1126/scitranslmed.adp8920

The Climate Change Burden on Immune Health: Are Persons Living with HIV More at Risk?

Woolley, G., Kroll, K., Hoffman, K., Ward, A., Corneli, A., Mudrak, S. V., Qureshi, M. U., Okeke, N. L., Chan, C., Jones, A. D., Tomaras, G. D., & Reeves, R. K. (2024). The Climate Change Burden on Immune Health: Are Persons Living with HIV More at Risk?. AIDS research and human retroviruses40(10), 549–554. https://doi.org/10.1089/AID.2024.0050

Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination

Collier, A. Y., McMahan, K., Jacob-Dolan, C., Liu, J., Borducchi, E. N., Moss, B., & Barouch, D. H. (2024). Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination. JAMA332(19), 1669–1672. https://doi.org/10.1001/jama.2024.20951

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

Kenny, A., van Duijn, J., Dintwe, O., Heptinstall, J., Burnham, R., Sawant, S., Zhang, L., Mielke, D., Khuzwayo, S., Omar, F. L., Stanfield-Oakley, S., Keyes, T., Dunn, B., Goodman, D., Fong, Y., Benkeser, D., Zou, R., Hural, J., Hyrien, O., Juraska, M., … Imbokodo Study and Correlates Group (2024). Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. EBioMedicine108, 105320. https://doi.org/10.1016/j.ebiom.2024.105320

Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates

Vanshylla, K., Tolboom, J., Stephenson, K. E., Feddes-de Boer, K., Verwilligen, A., Rosendahl Huber, S. K., Rutten, L., Schuitemaker, H., Zahn, R. C., Barouch, D. H., & Wegmann, F. (2024). Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates. NPJ vaccines9(1), 179. https://doi.org/10.1038/s41541-024-00974-1

Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques

Tong X, Wang Q, Jung W, Chicz TM, Blanc R, Parker LJ, Barouch DH, McNamara RP. Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques. iScience. 2024 Jun 4;27(9):110174. doi: 10.1016/j.isci.2024.110174. PMID: 39224511; PMCID: PMC11367469.